Elevated hemoglobin A1c is associated with readmission but not complications

Asian Cardiovascular and Thoracic Annals

Volumn 22, Issue 7, 2014, Pages 800-806

  Engoren, Milo ^a,b   Schwann, Thomas A ^a,c   Habib, Robert H ^d  

^a ST VINCENT MERCY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c MEDICAL COLLEGE OF OHIO   (United States)

^d AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Coronary artery bypass; Diabetes mellitu; glycosylated; Hemoglobin A; Patient readmission; Postoperative complications

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE; HEMOGLOBIN A1C; HYPERGLYCEMIC AGENT; INSULIN; BIOLOGICAL MARKER; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; COMORBIDITY; COMPARATIVE STUDY; CONGESTIVE HEART FAILURE; CORONARY ARTERY BYPASS SURGERY; DEMOGRAPHY; DRUG WITHDRAWAL; FEMALE; GLUCOSE BLOOD LEVEL; HEART FAILURE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HEMOGLOBIN BLOOD LEVEL; HOSPITAL READMISSION; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN INFUSION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PERIPHERAL VASCULAR DISEASE; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; RETROSPECTIVE STUDY; SURGICAL WOUND; VERY ELDERLY; ADVERSE EFFECTS; BLOOD; CHI SQUARE DISTRIBUTION; CORONARY ARTERY BYPASS GRAFT; MIDDLE AGED; MORTALITY; PREOPERATIVE PERIOD; RISK; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; TIME; TREATMENT OUTCOME; UPREGULATION;

AGED; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; COMORBIDITY; CORONARY ARTERY BYPASS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PATIENT READMISSION; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE PERIOD; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; UP-REGULATION;

EID: 84907376501     PISSN: 02184923     EISSN: 18165370     Source Type: Journal    
DOI: 10.1177/0218492313515895     Document Type: Article

References (20)

1. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2005 ; 28 (Suppl 1). S4-36 - S4-36
2. Engoren M, Habib RH, Zacharias A, et al. The prevalence of elevated hemoglobin A1c in patients undergoing coronary artery bypass surgery. J Cardiothorac Surg. 2008 ; 3: 63-63
3. Halkos ME, Puskas JD, Lattouf OM, et al. Elevated preoperative hemoglobin A1c level is predictive of adverse events after coronary artery bypass surgery. J Thorac Cardiovasc Surg. 2008 ; 136: 631-40-631-40
4. Halkos ME, Lattouf OM, Puskas JD, et al. Elevated preoperative hemoglobin A1c level is associated with reduced long-term survival after coronary artery bypass surgery. Ann Thorac Surg. 2008 ; 86: 1431-7-1431-7
5. Knapik P, Cieśla D, Filipiak K, Knapik M, Zembala M. Prevalence and clinical significance of elevated preoperative glycosylated hemoglobin in diabetic patients scheduled for coronary artery surgery. Eur J Cardiothorac Surg. 2011 ; 39: 484-9-484-9
6. Strahan S, Harvey RM, Campbell-Lloyd A, Beller E, Mundy J, Shah P. Diabetic control and coronary artery bypass: effect on short-term outcomes. Asian Cardiovasc Thorac Ann 2013; 21:281-7. Available at: http://aan.sagepub. com/content/21/3/281. Accessed November 12, 2013.
7. Hudson CC, Welsby IJ, Phillips-Bute B, et al. Glycosylated hemoglobin levels and outcome in non-diabetic cardiac surgery patients. Can J Anaesth. 2010 ; 57: 565-72-565-72
8. International Expert Committee. International Expert Committee Report on the role of the A1C Assay in the diagnosis of diabetes. Diabetes Care. 2009 ; 32: 1327-34-1327-34
9. Skyler JS, Bergenstal R, Bonow RO, et al. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Diabetes Care. 2009 ; 32: 187-92-187-92
10. Healy SJ, Black D, Harris C, et al. Inpatient diabetes education is associated with less frequent hospital readmission among patients with poor glycemic control. Diabetes Care. 2013 ; 36: 2960-7-2960-7
11. Kinoshita T, Asai T, Suzuki T, Lorenz A, Dungan KM. Preoperative hemoglobin A1c predicts atrial fibrillation after off-pump coronary bypass surgery. Eur J Cardiothorac Surg. 2012 ; 41: 102-7-102-7
12. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001 ; 345: 1359-67-1359-67
13. Ingeman A, Andersen G, Hundborg HH, Svendsen ML, Johnsen SP. In-hospital medical complications, length of stay, and mortality among stroke unit patients. Stroke. 2011 ; 42: 3214-8-3214-8
14. Thourani VH, Weintraub WS, Stein B, et al. Influence of diabetes mellitus on early and late outcome after coronary artery bypass grafting. Ann Thorac Surg. 1999 ; 67: 1045-52-1045-52
15. Carson JL, Scholz PM, Chen AY, Peterson ED, Gold J, Schneider SH. Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery. J Am Coll Cardiol. 2002 ; 40: 418-23-418-23
16. Woods SE, Smith JM, Sohail S, Sarah A, Engle A. The influence of type 2 diabetes mellitus in patients undergoing coronary artery bypass graft surgery: an 8-year prospective cohort study. Chest. 2004 ; 126: 1789-95-1789-95
17. Rajakaruna C, Rogers CA, Suranimala C, Angelini GD, Ascione R. The effect of diabetes mellitus on patients undergoing coronary surgery: a risk-adjusted analysis. J Thorac Cardiovasc Surg. 2006 ; 132: 802-10-802-10
18. Calafiore AM, Di Mauro M, Di Giammarco G, et al. Effect of diabetes on early and late survival after isolated first coronary bypass surgery in multivessel disease. J Thorac Cardiovasc Surg. 2003 ; 125: 144-54-144-54
19. Filsoufi F, Rahmanian PB, Castillo JG, Mechanick JI, Sharma SK, Adams DH. Diabetes is not a risk factor for hospital mortality following contemporary coronary artery bypass grafting. Interact Cardiovasc Thorac Surg. 2007 ; 6: 753-8-753-8
20. Furnary AP, Wu Y. Eliminating the diabetic disadvantage: the Portland Diabetic Project. Semin Thorac Cardiovasc Surg. 2006 ; 18: 302-8-302-8